Prix Galien Greece’s Honorary Awards recognize distinguished personalities that improve the human condition
Prix Galien Greece’s Honorary Awards recognize distinguished personalities that improve the human condition
The Galien Scientific Research Award is presented to Greek scientists who have made significant contributions to innovation through the development of innovative ideas, products or methods for the diagnosis or treatment of diseases.
The Galien Scientific Research Award was presented to internationally renowned researcher Dr. Vasso Apostolopoulos, Distinguished Professor, PhD, School of Health and Biomedical Sciences, Director, Healthy Lifespan and Chronic Diseases Theme, RMIT University, Australia.
The award was presented by Prime Minister Kyriakos Mitsotakis and H.E. the Ambassador of Australia, Alison Duncan.
In international rankings, Vasso Apostolopoulos is ranked among the world's leading researchers. Her greatest achievement was the development of the first personalized breast cancer vaccine in 2015. She has also contributed to the development of vaccines for other forms of cancer, such as ovarian and pancreatic cancer, which are currently at the clinical trial stage. In addition, she is pioneering vaccines for other diseases, such as multiple sclerosis, as well as vaccines aimed at helping people overcome drug addiction, based on technology she herself invented and which is now being used by leading research groups in vaccine development.
The Galien Scientific Research Award was presented to Christos Kyratsous, Senior Vice President of Research at Regeneron Pharmaceuticals Inc.
The award was accepted on behalf of Mr. Kyratsous by Stelios Papadopoulos, Chairman of Biogen Inc. The award was presented by the Deputy Minister of Health, Zoi Rapti.
The award was presented honoris causa to Professor Georgios Chrousos, Professor of Pediatrics, in recognition of his outstanding research work, which places him among the leading Greek scientists internationally.
The Galien Scientific Research Award was presented to Dr. Menelas N. Pangalos, FRSB, FMedSci, EVP & President, BioPharmaceuticals R&D, AstraZeneca, in recognition of his outstanding research work.
The award was presented to Nektarios Tavernarakis, Chairman of the Board of Directors of the Foundation for Research and Technology – Hellas (FORTH), Research Director at the Institute of Molecular Biology and Biotechnology, and Professor at the School of Medicine of the University of Crete, in recognition of his outstanding research work in Greece.
The award was presented hors prix to Dr. Georgios Kollias, biologist and researcher at the Alexander Fleming Biomedical Sciences Research Center, Professor at the School of Medicine of the National and Kapodistrian University of Athens, and Member of the Academy of Athens, in recognition of his decisive international contribution to the conception and advancement of biological anti-TNF therapies for rheumatoid arthritis, as well as for a series of studies that identified molecular and cellular mechanisms of disease pathogenesis and novel therapeutic targets in transgenic models of chronic inflammatory and autoimmune diseases, including inflammatory bowel diseases and multiple sclerosis.